Atwater Carey First Aid Kits Have Recalled Triad Povidone Iodine Pads

Individuals who have certain Atwater Carey First Aid Kits are being warned that some of the kits were shipped with Triad Povidone Iodine Prep Pads, which have been recalled due to possible bacterial contamination.

Wisconsin Pharmaceutical Company issued a Triad prep pad warning on April 21, indicating that consumers who own some first aid kits distributed by the company should not use the iodine prep pads that were included.

The kits affected by the warning include the following products under the Atwater Carey label:

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More
  • Personal First Aid Kit, Part Number 158A, UPC Code 3 68093 00158 9
  • Dayhiker First Aid Kit, Part Number 159A, UPC Code 3 68093 00159 6
  • Backpacker First Aid Kit, Part Number 160A, UPC Code 3 68093 00160 2
  • Light & Dry #1 Kit, Part Number 273, UPC Code 3 68093 00273 9
  • Light & Dry #2 Kit, Part Number 274, UPC Code 3 68093 00274 6
  • Light & Dry #3 Kit, Part Number 275, UPC Code 3 68093 00275 3
  • Marine First Aid Kit, Part Number 299, UPC Code 3 68093 00299 9

Wisconsin Pharmaceutical says that the first aid kits currently being produced do not contain the recalled Triad prep pads. Only the prep pads in the kits listed are suspected of being contaminated.

A Triad Povidone Iodine Prep Pad recall was issued on March 15 after the pads were discovered to be contaminated with Elizabethkingia meningoseptica, a bacteria that can cause meningitis, pneumonia, and necrotizing faciistis, also known as flesh-eating bacteria. The entire line of pads was pulled as a result.

The recall was part of a string of problems that ultimately led to the shutdown of H&P Industries, Inc., which was doing business as Triad.

FDA inspectors found systemic problems with sterilization procedures at the Triad production plant in Wisconsin. Public attention first came to the problem after a Triad alcohol prep pads recall was issued due to potential contamination with a different bacteria, Bacillus cereus, which has reportedly caused a number of users to suffer serious infections.

There have been a number of Triad prep pad lawsuits filed against the manufacturer in recent months; one by the parents of a two-year-old Houston boy who died due to a Bacillus cereus infection, another by a Tennessee man who alleges that a Triad alcohol prep pad infection left him permanently disabled, and a third that was filed by a 31-year-old Colorado woman with multiple sclerosis who alleges she contracted a life-threatening infection. The parents of a 10-year-old boy with leukemia who fell ill at The Children’s Hospital have also said they intend to file a lawsuit.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California
Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California (Posted 2 days ago)

A growing number of lawsuits against generic Depo-Provera manufacturers have been filed throughout the federal court system, each alleging that women were not adequately warned about the risk of meningioma brain tumors from the birth control shot.

Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024
Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (Posted 3 days ago)

Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.